Next 20 Records

Your search found 50 records, sorted by year and then date of acquisition.

1. Cost of Pharmacotherapy for Opioid Use Disorders Following Inpatient Detoxification. doc type
  McCollister, Kathryn ; Yang, Xuan ; Leff, Jared A. ; Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Rotrosen, John ; Schackman, Bruce R. ; Murphy, Sean M.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 9-14, 2018.
 
2. Baseline Characteristics by Randomization Status in NIDA-CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT). doc type
  May, Jeanine ; Salazar, Dagmar ; Novo, Patricia ; Shmueli-Blumberg, Dikla ; King, Jacquie ; Matthews, Abigail G. ; Rotrosen, John
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Montreal, Canada, June 17-22, 2017.
 
3. Comparative Effectiveness of Extended-Release Naltrexone versus Buprenorphine-Naloxone for Opioid Relapse Prevention (X:BOT): A Multicenter, Open-Label, Randomized Controlled Trial. doc type
  Novo, Patricia ; Lee, Joshua D. ; Nunes, Edward V. ; Bachrach, Ken ; Bailey, Genie L. ; Bhatt, Snehal ; Farkas, Sarah ; Fishman, Marc J. ; Gauthier, Phoebe ; Hodgkins, Candace C. ; King, Jacquie ; Lindblad, Robert ; Liu, David S. ; Matthews, Abigail G. ; May, Jeanine ; Peavy, K. Michelle ; Ross, Stephen ; Salazar, Dagmar ; Schkolnik, Paul ; Shmueli-Blumberg, Dikla ; Stablein, Don ; Subramaniam, Geetha A. ; Rotrosen, John
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 9-14, 2018.
 
4. Cost-Effectiveness of Extended-Release Naltrexone versus Buprenorphine-Naloxone to Prevent Opioid Relapse. doc type
  Murphy, Sean M. ; McCollister, Kathryn ; Leff, Jared A. ; Yang, Xuan ; Jeng, Philip J. ; Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Rotrosen, John ; Schackman, Bruce R.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 9-14, 2018.
 
5. Participants' Preferences for BUP-NX or XR-NTX and Associations with Induction Success and Relapse Rates in the NIDA-CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT). doc type
  King, Jacquie ; May, Jeanine ; Salazar, Dagmar ; Hoehn, Anne ; Shmueli-Blumberg, Dikla ; Novo, Patricia ; Choi-Kuaea, Yunhee ; Peavy, K. Michelle ; Wiebe, Rosson ; Lee, Joshua ; Rotrosen, John
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 9-14, 2018.
 
6. Baseline Characteristics of the Opioid Use Disorder Population Enrolled in NIDA-CTN-0051, "Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT)." doc type
  Novo, Patricia ; Nunes, Edward V. ; Scodes, Jennifer ; Pavlicova, Martina ; Lee, Joshua D. ; May, Jeanine ; Salazar, Dagmar ; Shmueli-Blumberg, Dikla ; Rotrosen, John
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Montreal, Canada, June 17-22, 2017.
 
7. Brief Report: Gender Differences in Demographic and Clinical Characteristics of Patients with Opioid Use Disorder Entering a Comparative Effectiveness Medication Trial. doc type
  Campbell, Aimee N. C. ; Barbosa-Leiker, Celestina ; Hatch-Maillette, Mary A. ; Mennenga, Sarah ; Pavlicova, Martina ; Scodes, Jennifer ; Saraiya, Tanya ; Mitchell, Shannon Gwin ; Rotrosen, John ; Novo, Patricia ; Nunes, Edward V. ; Greenfield, Shelly F.
 American Journal on Addictions 2018 (in press). [doi: 10.1111/ajad.12784].
 
8. Barriers and Facilitators Affecting the Implementation of Substance Use Screening in Primary Care Clinics: A Qualitative Study of Patients, Providers, and Staff. doc type
  McNeely, Jennifer ; Kumar, Pritika C. ; Rieckmann, Traci R. ; Sedlander, Erica ; Farkas, Sarah ; Chollak, Christine ; Kannry, Joseph L. ; Vega, Aida ; Waite, Eva A. ; Peccoralo, Lauren A. ; Rosenthal, Richard N. ; McCarty, Dennis ; Rotrosen, John
 Addiction Science & Clinical Practice 2018;13:8. [doi: 10.1186/s13722-018-0110-8].
 
9. Usability Testing to Guide Development of a Clinical Decision Support System for Substance Use Screening and Interventions in Primary Care. doc type
  McNeely, Jennifer ; Kushniruk, Andre ; Farkas, Sarah ; Vega, Aida ; Waite, Eva ; Peccoralo, Lauren A. ; Harris, Melanie ; Chollak, Christine ; Rosenthal, Richard N. ; Rotrosen, John ; Kannry, Joseph
 Presented at the American Medical Informatics Association (AMIA) annual symposium Washington, DC., November 4-8, 2017.
 
10. Comparative Effectiveness of Extended-Release Naltrexone Versus Buprenorphine-Naloxone for Opioid Relapse Prevention (X:BOT): A Multicentre, Open-Label, Randomised Controlled Trial. doc type doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bachrach, Ken ; Bailey, Genie L. ; Bhatt, Snehal ; Farkas, Sarah ; Fishman, Marc J. ; Gauthier, Phoebe ; Hodgkins, Candace C. ; King, Jacquie ; Lindblad, Robert ; Liu, David S. ; Matthews, Abigail G. ; May, Jeanine ; Peavy, K. Michelle ; Ross, Stephen ; Salazar, Dagmar ; Schkolnik, Paul ; Shmueli-Blumberg, Dikla ; Stablein, Don ; Subramaniam, Geetha A. ; Rotrosen, John
 The Lancet 2018;391(10118):309-318. [doi: 10.1016/S0140-6736(17)32812-X].
 
11. Ethical and Clinical Safety Considerations in the Design of an Effectiveness Trial: A Comparison of Buprenorphine Versus Naltrexone Treatment for Opioid Dependence. doc type
  Nunes, Edward V. ; Lee, Joshua D. ; Sisti, Dominic ; Segal, Andrea ; Caplan, Arthur ; Fishman, Marc J. ; Bailey, Genie L. ; Brigham, Gregory S. ; Novo, Patricia ; Farkas, Sarah ; Rotrosen, John
 Contemporary Clinical Trials 2016;51:34-43. [doi: 10.1016/j.cct.2016.09.006].
 
12. NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study Design and Rationale. doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bailey, Genie L. ; Brigham, Gregory S. ; Cohen, Allan J. ; Fishman, Marc J. ; Ling, Walter ; Lindblad, Robert ; Shmueli-Blumberg, Dikla ; Stablein, Don ; May, Jeanine ; Salazar, Dagmar ; Liu, David S. ; Rotrosen, John
 Contemporary Clinical Trials 2016;50:253-264. [doi: 10.1016/j.cct.2016.08.004].
 
13. Buprenorphine-Naloxone plus Naltrexone for the Treatment of Cocaine Dependence: The Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Ling, Walter ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Mooney, Larissa J. ; Thomas, Christie ; Ang, Alfonso ; Matthews, Abigail G. ; Hasson, Albert L. ; Annon, Jeffrey J. ; Sparenborg, Steven ; Liu, David S. ; McCormack, Jennifer ; Church, Sarah ; Swafford, William ; Drexler, Karen ; Schuman, Carolyn ; Ross, Stephen ; Wiest, Katharina L. ; Korthuis, P. Todd ; Lawson, William ; Brigham, Gregory S. ; Knox, Patricia C. ; Dawes, Michael ; Rotrosen, John
 Addiction 2016;111(8):1416-1427. [doi: 10.1111/add.13375].
 
14. Substance-Use Screening and Interventions in Dental Practices: Survey of Practice-Based Research Network Dentists Regarding Current Practices, Policies, and Barriers. doc type
  McNeely, Jennifer ; Wright, Shana ; Matthews, Abigail G. ; Rotrosen, John ; Shelley, Donna ; Buchholz, Matthew P. ; Curro, Frederick A.
 Journal of the American Dental Association 2013;144(6):627-638.
 
15. Hepatitis B Virus and Hepatitis C Virus Services Offered by Substance Abuse Treatment Programs in the United States. doc type
  Bini, Edmund J. ; Kritz, Steven Allan ; Brown, Lawrence S. Jr. ; Robinson, James A. ; Calsyn, Donald A. ; Alderson, Donald ; Tracy, Kathlene ; McAuliffe, Patrick ; Smith, Cheryl ; Rotrosen, John
 Journal of Substance Abuse Treatment 2012;42(4):438–445. [doi: 10.1016/j.jsat.2011.09.007].
 
16. Smoking Cessation Treatment among Patients in Community-Based Substance Abuse Rehabilitation Programs: Exploring Predictors of Outcome as Clues Toward Treatment Improvement. doc type
  Reid, Malcolm S. ; Jiang, Huiping ; Fallon, Bryan ; Sonne, Susan C. ; Rinaldi, Paul ; Turrigiano, Eva ; Arfken, Cynthia L. ; Robinson, James A. ; Rotrosen, John ; Nunes, Edward V.
 American Journal of Drug and Alcohol Abuse 2011;37(5):472-478. [doi: 10.3109/00952990.2011.596981].
 
17. Program, Counselor, and Patient Variability in the Alliance: A Multilevel Study of the Alliance in Relation to Substance Use Outcomes. doc type
  Crits-Christoph, Paul ; Hamilton, Jessica L. ; Ring-Kurtz, Sarah ; Gallop, Robert ; McClure, Bridget ; Kulaga, Agatha ; Rotrosen, John
 Journal of Substance Abuse Treatment 2011;40(4):405-413. [doi: 10.1016/j.jsat.2011.01.003].
 
18. Barriers to Providing Health Services for HIV/AIDS, Hepatitis C Virus Infection and Sexually Transmitted Infections in Substance Abuse Treatment Programs in the United States. doc type
  Bini, Edmund J. ; Kritz, Steven Allan ; Brown, Lawrence S. Jr. ; Robinson, James A. ; Alderson, Donald ; Rotrosen, John
 Journal of Addictive Diseases 2011;30(2):98–109. [doi: 10.1080/10550887.2011.554780].
 
19. Substance Abuse Treatment as HIV Prevention: More Questions than Answers. doc type
  Brown, Lawrence S. Jr. ; Kritz, Steven Allan ; Bini, Edmund J. ; Louie, Benjamin ; Robinson, James A. ; Alderson, Donald ; Rotrosen, John
 Journal of the National Medical Association 2010;102(12):1183-1191.
 
20. HIV/AIDS-Related Health Services in Substance Abuse Treatment Programs. doc type
  Brown, Lawrence S. Jr. ; Kritz, Steven Allan ; Bini, Edmund J. ; Louie, Benjamin ; Robinson, James A. ; Alderson, Donald ; Rotrosen, John
 Presented at the Addiction Health Services Research Conference, Lexington, Kentucky, October 25-27, 2010.
 

  Next 20 Records

Powered by DB/Text WebPublisher, from Inmagic WebPublisher PRO